BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6575697)

  • 1. The occurrence and clinical relevance of fibrin fragments in blood.
    Gaffney PJ
    Ann N Y Acad Sci; 1983 Jun; 408():407-23. PubMed ID: 6575697
    [No Abstract]   [Full Text] [Related]  

  • 2. [An analysis of disseminated intravascular coagulation by fibrinopeptides].
    Gando S; Tedo I
    Rinsho Ketsueki; 1988 Dec; 29(12):2250-5. PubMed ID: 3150013
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinogen derivatives in plasma.
    Lane DA
    Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinopeptide A increases after chorionic villus sampling.
    Al-Gailani F; Elias S; Simpson JL; Green D
    Prenat Diagn; 1987 Oct; 7(8):557-60. PubMed ID: 3684963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin polymerization sites in fibrinogen and fibrin fragments.
    Budzynski AZ; Olexa SA; Pandya BV
    Ann N Y Acad Sci; 1983 Jun; 408():301-14. PubMed ID: 6575691
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen proteolysis by thrombin, plasmin and platelet release in relation to disseminated intravascular coagulation.
    Nossel HL
    Bibl Haematol; 1983; (49):151-62. PubMed ID: 6230075
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
    Uchiba M; Okajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercoagulability.
    Hirsh J
    Semin Hematol; 1977 Oct; 14(4):409-25. PubMed ID: 72416
    [No Abstract]   [Full Text] [Related]  

  • 12. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
    Ikematsu S; Kato M; Kuroso K
    Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
    Kobayashi N
    Rinsho Byori; 1989 Mar; 37(3):231-3. PubMed ID: 2746916
    [No Abstract]   [Full Text] [Related]  

  • 14. Crosslinking of monomeric fibrin by factor XIIIa.
    Dardik BN; Shainoff JR
    Thromb Haemost; 1979 Oct; 42(3):864-72. PubMed ID: 505402
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coagulation-fibrinolysis abnormalities in acute stage hypertensive intra-cerebral hemorrhage and head injury (preliminary report). With special reference to fibrinopeptides A and B beta 15-42].
    Touho H; Hino A; Suzuki K; Kubo S; Hirakawa K
    Neurol Med Chir (Tokyo); 1985 Mar; 25(3):203-8. PubMed ID: 2409465
    [No Abstract]   [Full Text] [Related]  

  • 16. Disseminated intravascular coagulation: the application and utility of diagnostic tests.
    Ockelford PA; Carter CJ
    Semin Thromb Hemost; 1982 Jul; 8(3):198-216. PubMed ID: 6215711
    [No Abstract]   [Full Text] [Related]  

  • 17. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular markers of hemostatic mechanisms--fibrinopeptide B beta 1-42].
    Kuroso K
    Rinsho Byori; 1989 Mar; 37(3):234-9. PubMed ID: 2664279
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.